Application of CYP3A4 in vitro data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction-Reference-Cited by-同舟云学术

Application of CYP3A4 in vitro data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction

Published:2008-05 Issue:5 Volume:65 Page:680-692
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Youdim Kuresh A.,Zayed Aref,Dickins Maurice,Phipps Alex,Griffiths Michelle,Darekar Amanda,Hyland Ruth,Fahmi Odette,Hurst Susan,Plowchalk David R.,Cook Jack,Guo Feng,Obach R. Scott

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2007.03070.x/fullpdf

Reference28 articles.

1. The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development

2. AN EVALUATION OF THE IN VITRO METABOLISM DATA FOR PREDICTING THE CLEARANCE AND DRUG-DRUG INTERACTION POTENTIAL OF CYP2C9 SUBSTRATES

3. Predicting drug pharmacokinetics in humans from in vitro metabolism studies

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment;Biomolecules;2024-01-12

2. Enhancing drug-drug Interaction Prediction by Integrating Physiologically-Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4;Expert Opinion on Drug Metabolism & Toxicology;2023-09-30

3. Roles of human cytochrome P450 3A4/5 in dexamethasone 6β-hydroxylation mediated by liver microsomes and humanized liver in chimeric mice metabolically suppressed with azamulin;Drug Metabolism and Pharmacokinetics;2023-06

4. Discovery Toxicology in Lead Optimization;The Handbook of Medicinal Chemistry;2023-02-03

5. Application of reaction phenotyping to address pharmacokinetic variability in patient populations;Overcoming Obstacles in Drug Discovery and Development;2023